Differential patient stratification by the breast cancer index Hox613/1L17BR ratio vs recurrence score (RS) plus quantitative ER expression in hormone receptor positive, node negative breast cancer

被引：0
|
作者：
Naughton, M. J.
Schroeder, B. E.
Operana, T. N.
Zhang, Y.
Schnabel, C. A.
机构：
[1] Washington Univ, St Louis, MO USA
[2] BioTheranostics Inc, San Diego, CA USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-08-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-08-09
引用
收藏
页数：1
相关论文
共 22 条
  • [21] Palbociclib (PAL) plus letrozole (L) as first-line (1) therapy (tx) in estrogen receptor-positive (ER plus )/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Efficacy and safety across patient (pt) subgroups.
    Finn, Richard S.
    Dieras, Veronique
    Rugo, Hope S.
    Joy, Anil A.
    Moulder, Stacy L.
    Walshe, Janice Maria
    Mukai, Hirofumi
    Shparyk, Yaroslav V.
    Park, In Hae
    Mori, Ave
    Lu, Dongrui
    Gauthier, Eric Roland
    Gelmon, Karen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Updated results from a phase 3 randomized clinical trial in participants (pts) with 1-3 positive lymph nodes (LN), hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) ≤ 25 randomized to endocrine therapy (ET) plus /- chemotherapy (CT): SWOG S1007 (RxPONDER)
    Kalinsky, Kevin M.
    Barlow, William E.
    Gralow, Julie R.
    Meric-Bernstam, Funda
    Albain, Kathy S.
    Hayes, Daniel F.
    Lin, Nancy U.
    Perez, Edith A.
    Goldstein, Lori A.
    Chia, Stephen K. L.
    Dhesy-Thind, Sukhbinder
    Rastogi, Priya
    Alba, Emilio
    Delaloge, Suzette
    Martin, Miguel
    Kelly, Catherine M.
    Ruiz-Borrego, Manuel
    Gil-Gil, Miguel
    Arce-Salinas, Claudia H.
    Brain, Etienne G. C.
    Lee, Eun Sook
    Pierga, Jean-Yves
    Bermejo, Begona
    Ramos-Vasquez, Manuel
    Jung, Kyung Hae
    Ferrero, Jean-Marc
    Schott, Anne
    Shak, Steven
    Sharma, Priyanka
    Lew, Danika
    Miao, Jieling
    Tripathy, Debasish
    Pusztai, Lajos
    Hortobagyi, Gabriel
    CANCER RESEARCH, 2022, 82 (04)
123